INFLUENCE OF ABC TRANSPORTERS’ GENETIC PROFILES IN THE DEVELOPMENT OF MONOCLONAL GAMMOPATHIES

EHA Library, Ana Bela Sarmento-Ribeiro, 99912

CIRCULATING MICRORNAS IN PLASMA OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Michaela Dostalova Merkerova, 99913

TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND AND DEATH RECEPTORS: RELEVANCE IN THE PATHOGENESIS OF MONOCLONAL GAMMOPATHIES

EHA Library, Catarina Geraldes, 99914

MUTATIONAL PROFILE IN MYELODYSPLASTIC SYNDROMES BY HIGH-DEPTH NEXT GENERATION SEQUENCING AND CLINICAL RELEVANCE

EHA Library, M Teresa Cedena, 99915

TS, MTHFR AND XRCC1 GENETIC VARIANTS AFFECT THE CLINICAL COURSE OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK

EHA Library, Federica Loscocco, 99916

SIRPB1: BIOMARKER OF RESPONSE TO 5-AZACITIDINE TREATMENT IN MDS AND AML PATIENTS

EHA Library, Viviana Guadagnuolo, 99917

RPS14 EXPRESSION IN MYELODYSPLASTIC SYNDROME WITHOUT 5Q DELETION

EHA Library, Keina Susana Quiroz Cervantes, 99918

IMMUNOGLOBULIN HEAVY/LIGHT CHAIN IMMUNOASSAYS FOR RESPONSE EVALUATION IN MULTIPLE MYELOMA: COMPARISON WITH IMMUNOFIXATION, SERUM FREE LIGHT CHAIN, AND MULTICOLOR FLOW- CYTOMETRY

EHA Library, Yasuhito Suehara, 99919

CLINICAL RELEVANCE OF IL-6 AND TNF-ALFA IN THE CHARACTERIZATION OF LEUKEMIC STEM CELLS IN MDS PATIENTS

EHA Library, Emília Cortesão, 99920

MOLECULAR PROFILE OF TRANSFORMED AND NON TRANSFORMED INDIAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Rekha Chaubey, 99921

MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS : EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE

EHA Library, Claudio Cerchione, 99922

IMPACT OF TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN ALPHA ON CARDIAC REMODELING IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: RESULTS FROM A PROSPECTIVE STUDY

EHA Library, Arboscello Eleonora, 99923

ACUTE MYELOID LEUKEMIA PROGRESSION IN ARGENTINEAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Alicia Enrico, 99924

PULMONARY INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING AZACYTIDINE TREATMENT

EHA Library, Roberto Latagliata, 99925

HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY.

EHA Library, Jose María Bastida, 99926

EFFECTIVENESS OF AZACITIDINE COMPARED TO CONVENTIONAL CARE REGIMENS FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASIA IN THE REAL-WORLD: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

EHA Library, Avinash Dinmohamed, 99927

CLINICAL FEATURES, TREATMENT DECISIONS AND TREATMENT OUTCOMES OF PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) IN THE REAL-WORLD: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

EHA Library, Avinash Dinmohamed, 99928

A NEW PROGNOSTIC INDEX TO PREDICT SHORT-TERM PROGNOSIS IN MDS PATIENTS TREATED WITH AZACITIDINE; COMBINATION OF P53 EXPRESSION AND CYTOGENETICS

EHA Library, Satoshi Nishiwaki, 99929

DIAGNOSIS, PROGNOSTICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) IN DAILY PRACTICE: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

EHA Library, Avinash Dinmohamed, 99930

THE UTILITY OF GRANULOCYTE MATURATION PATTERNS ASSESSED BY FLOW CYTOMETRY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME

EHA Library, Sylvia Meisenberg, 99931

PATIENTS WITH THERAPY-RELATED CHRONIC MYELOMONOCYTIC LEUKEMIA (TR-CMML) HAVE SHORTER MEDIAN OVERALL SURVIVAL THAN DE NOVO CMML (DN-CMML): MAYO CLINIC EXPERIENCE

EHA Library, Salih Subari, 99932

STAT3 EXPRESSION IS ASSOCIATED WITH POOR SURVIVAL IN YOUNG PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Sung-Hoon Jung, 99933

HEPATITIS B REACTIVATION IN MULTIPLE MYELOMA PATIENTS WITH RESOLVED HEPATITIS B UNDERGOING CHEMOTHERAPY

EHA Library, Ji Yun Lee, 99934

HEMATOLOGIC MALIGNANCIES, MOSTLY MYELODYSPLASTIC SYNDROMES AMONG 1740 INFLAMMATORY BOWEL DISEASE PATIENTS: LONG TERM FOLLOW-UP DATA FROM A TERTIARY CENTER

EHA Library, Ayse Salihoglu, 99935

IMPACT OF AZACITIDINE ON RED BLOOD CELL ALLOINMUNIZATION IN MYELODISPLASTIC SYNDROME

EHA Library, Sebastián Ortiz Zuluaga, 99936

IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROME (MDS) IN ROUTINE CLINICAL SETTING: AN INTERIM ANALYSIS OF THE NON-INTERVENTIONAL STUDY EXSEPT

EHA Library, Forian Nolte, 99937

HEMOCHROMATOSIS GENE MUTATIONS MAY AFFECT THE SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Marko Lucijanic, 99938

P53 EXPRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AT DIAGNOSIS AND FOLLOWING TREATMENT WITH AZACITIDINE

EHA Library, Su Wai Maung, 99939

SUBGROUP ANALYSES OF A PHASE 3 STUDY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FAILING HMA TREATMENT: IDENTIFICATION OF A HOMOGENEOUS POPULATION WHO BENEFIT FROM RIGOSERTIB THERAPY

EHA Library, Gianluca Gaidano, 99940

THE ROLE OF INITIAL 18F-FDG PET/CT IN PATIENTS WITH POEMS SYNDROME

EHA Library, Hyunsoo Cho, 99941

TRIAL EFFICACY VS REAL WORLD EFFECTIVENESS IN FIRST LINE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Johan Liwing, 99942

LONG-LASTING HEMATOLOGIC RESPONSE TO AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: UPDATE OF CLINICAL RESULTS FROM A SINGLE INSTITUTION

EHA Library, Carlo Finelli, 99943

ELEVATED FACTOR VIII LEVELS CARRY A POOR OVERALL SURVIVAL IN NEWLY DIAGNOSED SYSTEMIC LIGHT CHAIN (AL) AMYLOIDOSIS PATIENTS.

EHA Library, Ashutosh Wechalekar, 99944

PROGNOSTIC IMPACT OF SERUM FREE LIGHT CHAIN (SFLC) EVALUATION IN PATIENTS WITH NEWLY DIAGNOSED SYMPTOMATIC MULTIPLE MYELOMA (MM) RECEIVING BORTEZOMIB (BTZ) -BASED REGIMENS

EHA Library, Paola Tacchetti, 99945

EVALUATION OF THE CHROMOSOMAL ABERRATION PATTERN IN IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS

EHA Library, Min-Young Lee, 99946

CIRCULATING BCMA BINDING TO ITS LIGAND BAFF PREVENTS NORMAL ANTIBODY PRODUCTION IN MULTIPLE MYELOMA PATIENTS

EHA Library, James Berenson, 99947

IMPACT OF SERUM ALPHA 1-ACID GLYCOPROTEIN (AAG), A POTENTIAL PATIENT SELECTION MARKER FOR FILANESIB, ON SURVIVAL AND RESPONSE TO CONVENTIONAL THERAPIES IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA (RMM)

EHA Library, Brian Tunquist, 99948

ANALYSIS OF RHOU AND RHOV EXPRESSION IN MULTIPLE MYELOMA REVEALS A POSSIBLE CORRELATION WITH BONE MARROW DEPENDENCE

EHA Library, Sara Nunes, 99949

A POPULATION BASED STUDY OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS IN LATVIA (2007-2009 YEARS)

EHA Library, Daiga Auzina, 99950

OUTCOME OF NEWLY DIAGNOSED SYMPTOMATIC MULTIPLE MYELOMA IN VERY ELDERLY PATIENTS (AGED 80 YEARS OR MORE)

EHA Library, Nicola Sgherza, 99951

INTENTION TO TREAT VS AGE OF DIAGNOSIS. ANALYSIS OF BENEFITIAL EFFECT OF NEW AGENTS IN THE TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Belen Ballina, 99952

THE AMPLIFICATION OF 1Q21 IS AN ADVERSE PROGNOSTIC FACTOR IN CHINESE PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Lijuan Chen, 99953

USE OF EARLY CHANGES IN GENE EXPRESSION OF PLASMA CELLS MAY PREDICT RESPONSE TO BORTEZOMIB IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Konstantinos Liapis, 99954

ANTI-GRP78 MONOCLONAL ANTIBODY PAT-SM6 IN REFRACTORY AND EXTRAMEDULLARY MULTIPLE MYELOMA: PRECLINICAL AND CLINICAL EVIDENCE FOR A COMBINATORIAL STRATEGY WITH NOVEL AGENTS

EHA Library, Leo Rasche, 99955

CLINICAL FEATURES, PROGNOSIS AND TREATMENT OUTCOME OF THE OF THE EXTRAOSSEUS PLASMA CELL NEOPLASIA: PLASMACYTOMA, MULTIPLE MYELOMA AND PRIMARY PLASMA CELL LEUKEMIA

EHA Library, Jelena Jelicic, 99956

DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING PARAMETERS CORRELATE WITH ANGIOPOIETIN-1/ANGIOPOIETIN-2 RATIO AND OTHER HIGH-RISK FEATURES IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Evangelos Terpos, 99957

SERUM LEVELS OF VON WILLEBRAND FACTOR (VWF) BUT NOT OF ADAMTS-13 PREDICT FOR EARLY DEATH IN PATIENTS WITH AL AMYLOIDOSIS, INDEPENDENTLY OF CARDIAC BIOMARKERS

EHA Library, Efstathios Kastritis, 99958

ANALYSIS OF OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS WITH 3 LINES OF THERAPY INCLUDING A PI AND AN IMID, OR DOUBLE REFRACTORY TO A PI AND AN IMID USING REAL WORLD DATA

EHA Library, Saad Usmani, 99959

FINDING MOLECULAR/EPIGENETIC SIGNATURES IN PHILADELPHIA NEGATIVE MPNS: A NOVEL TOOL FOR STRENGTHENING DISEASE STATUS CLASSIFICATION AND TAILORING PERSONALIZED DRUG STRATEGIES

EHA Library, Miguel Martin, 99960

SK053, AN INHIBITOR OF ENZYMES INVOLVED IN ALLOSTERIC DISULFIDE BONDS FORMATION, TARGETS EXPRESSION OF HISTONE GENES, SHOWS POTENT ANTI-LEUKEMIC EFFECTS AND INDUCES DIFFERENTIATION OF HUMAN AML CELLS

EHA Library, Justyna Chlebowska, 99961

ASSESSING TREATMENT RESPONSE IN MULTIPLE MYELOMA: IMPLICATIONS OF USING BONE MARROW PLASMA CELL CONTENT AS A MARKER OF DISEASE BURDEN

EHA Library, A. Kamel Abou Hussein, 99962

PATIENT EXPERIENCE WITH LIGHT CHAIN AMYLOIDOSIS: A SURVEY FROM THE AMYLOIDOSIS RESEARCH CONSORTIUM

EHA Library, Isabelle Lousada, 99963

TO TAKE HOME: HOW MUCH VALUE IS LOW BURDEN OF JAK2 V617F ALLELE MUTATION?

EHA Library, Laura Torres Miñana, 99964

CHRONIC INFLAMMATION BIOMARKERS IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Olivera Mitrovic, 99965

THE PRESENCE OF THE JAK2V617F POINT MUTATION AFFECTS OSTEOCLAST FUNCTION IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Emmanouil Spanoudakis, 99966

PLATELET ANALYSIS INCREASES THE DETECTION OF MUTATIONS IN TRIPLE-NEGATIVE ESSENTIAL THROMBOCYTHEMIA PATIENTS

EHA Library, Anna Angona, 99967

BONE MARROW STROMA MEDIATED PROTECTION OF MPN CELLS FROM RUXOLITINIB- AND VORINOSTAT-INDUCED APOPTOSIS REQUIRES MAPK-JNK AND PI3K-AKT/PKB SIGNALING PATHWAY ACTIVATION

EHA Library, Antonio De Almeida, 99968

FREQUENCY AND ALLELE BURDEN OF CALR MUTATIONS IN CHINESE WITH ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS WITHOUT JAK2 V617F OR MPL MUTATIONS

EHA Library, Guo-Rui Ruan, 99969

SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED MULTIPLE MYELOMA

EHA Library, beatrice zannetti, 99970

THE ANTIPROLIFERATIVE EFFECT OF SIMVASTATIN IS ASSOCIATED WITH EPIGENETIC MECHANISMS IN NEOPLASTIC MAST CELLS

EHA Library, Heidrun Karlic, 99971

RE-TREATMENT VS CHANGE THERAPY IN FIRST RELAPSE: POST-HOC ANALYSIS OF 476 PATIENTS WITH MULTIPLE MYELOMA (MM) INCLUDED IN TWO PROSPECTIVE TRIALS

EHA Library, Massimo Offidani, 99972

AL AMYLOIDOSIS AND QUALITY OF LIFE OUTCOMES

EHA Library, Rahma Warsame, 99973

HEAVY/LIGHT CHAIN IMMUNOPARESIS AS A NOVEL MARKER OF POOR OUTCOMES IN SYSTEMIC AL AMYLOIDOSIS

EHA Library, Ashutosh Wechalekar, 99974

FIRST REPORT OF A PROSPECTIVE STUDY ON WHOLE-BODY DYNAMIC CONTRAST ENHANCED MRI IN NEWLY DIAGNOSED MYELOMA PATIENTS TREATED WITH UP-FRONT AUTOLOGOUS TRANSPLANTATION: DESCRIPTIVE STUDY AT BASELINE

EHA Library, Karim Belhadj, 99975

IMPACT OF NF-KB EXPRESSION IN THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB IN FRONTLINE REGIMENS

EHA Library, Catarina Geraldes, 99976

BORTEZOMIB CONSOLIDATION FOLLOWING ASCT FOR MULTIPLE MYELOMA (MM) IMPROVES RESPONSE DEPTH, WITH ACCEPTABLE TOXICITY AND PRESERVED QUALITY OF LIFE

EHA Library, Neil Rabin, 99977

SUPERIOR EFFICACY OF VTD OVER VCD BEFORE AND AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, Michele Cavo, 99978

CAN OVERALL SURVIVAL BE IMPROVED IN ELDERLY MULTIPLE MYELOMA PATIENTS?

EHA Library, Bart M.S.Heeg, 99979

MUTATIONAL STATUS AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STRICTLY WHO 2008-DIAGNOSED ESSENTIAL THROMBOCYTHEMIA: A MONOCENTRIC STUDY

EHA Library, Irene Bertozzi, 99980

MATRIX METALLOPROTEINASE 2,3,9,10 AND 13 GENE MUTATIONS IN MYELOPROLIFERATIVE DISEASES

EHA Library, Senem Maral, 99981

SUBCUTANEOUS VERSUS INTRAVENOUS BORTEZOMIB: A REAL-LIFE STUDY ON MULTIPLE MYELOMA PATIENTS

EHA Library, SILVIA MANGIACAVALLI, 99982

CLINICAL FEATURES OF JAPANESE POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PATIENTS HARBORING CALR, JAK2V617F, JAK2EX12DEL, AND MPLW515L/K MUTATIONS

EHA Library, Masahiro Okabe, 99983

ACCURACY OF THE SERUM TOTAL LIGHT CHAIN RATIO AS A PREDICTOR OF ABNORMAL SERUM FREE LIGHT CHAIN RATIOS

EHA Library, Marta Pereira, 99984

HIGH PREVALENCE OF RAS PATHWAY MUTATIONS IN CMML PATIENTS WITH HIGH COLONY GROWTH

EHA Library, Klaus Geissler, 99985

CLINICAL DIFFERENCES IN ESSENTIAL THROMBOCYTHEMIA PATIENTS WITH AND WITHOUT THROMBOTIC COMPLICATIONS

EHA Library, Anastasiia Zherniakova, 99986

CIRCULATING ENDOTHELIAL CELLS (CEC) AS A SURROGATE MARKER FOR EVOLUTION IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Mercedes Rodriguez-Calvillo, 99987

SIMULATION IN CONTINUING EDUCATION: IMPROVING HEMATOLOGIST EVIDENCE-BASED DECISIONS FOR MYELOPROLIFERATIVE NEOPLASM MANAGEMENT

EHA Library, Emily Van Laar, 99989

SERUM LEVELS OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS ARE ELEVATED IN JAK2V617F MUTATED COMPARED TO CALR MUTATED MYELOFIBROSIS AND TRIPLE NEGATIVE ESSENTIAL THROMBOCYTEMIA PATIENTS

EHA Library, Luciene Terezina Lima, 99990

THE MUTATION OF THE SPLICING GENE SRSF2 PERFORMED BY HRM SCREENING IN THE DIAGNOSIS OF CMML.

EHA Library, Melissa Torres Ochando, 99991

TNIP1 AS A NOVEL REARRANGEMENT PARTNER FOR 5Q32 PDGFRB IN EOSINOPHILIA-ASSOCIATED MYELOID NEOPLASM

EHA Library, Arjan Buijs, 99992

MECHANISMS OF FATAL CARDIOTOXICITY FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY AND A METHOD FOR ITS PREVENTION

EHA Library, Takuro Nishikawa, 99993

PROGRESSION TO MYELOPROLIFERATIVE NEOPLASMS WAS ASSOCIATED WITH MUTATIONS OF THE JAK2 AND CALR GENES IN PATIENTS WITH IDIOPATHIC LEUKOCYTOSIS AND THROMBOCYTOSIS

EHA Library, Naoki Mori, 99994

INTERLABORATORY EVALUATION OF TARGETED NEXT GENERATION SEQUENCING FOR MYELOPROLIFERATIVE NEOPLASMS ASSOCIATED MUTATIONS

EHA Library, Emmanuelle Verger, 99995

THE EFFECTS OF -ADRENERGIC AGONIST OF ISOPROTERENOL ON MIR-886-3P AND MIR-23A EXPRESSION IN HUMAN MESENCHYMAL STEM CELLS

EHA Library, Saeid Kaviani, 99996

COMPARISON OF CONDITIONING REGIMENS FOR RELAPSED / REFRECTORY LYMPHOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION: BEAM VS HIGH DOSE ICE

EHA Library, Ahmet Kursad Gunes, 99997

FERTILITY IN OUR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: RESULTS FOR 23 YEARS OF EXPERIENCE

EHA Library, Pervin Topcuoglu, 99998

CD30 EXPRESSION ON NEOPLASTIC MAST CELLS IN SYSTEMIC MASTOCYTOSIS – CORRELATION OF ASSESSMENT BY IMMUNOHISTOCHEMISTRY AND MULTIPARAMETER FLOW CYTOMETRY WITH RESPECT TO CLINICAL PARAMETERS

EHA Library, Frauke Bellos, 99999

INCIDENCE OF CALR MUTATIONS IN PATIENTS WITH CEREBRAL VENOUS THROMBOSIS WITHOUT OVERT CHRONIC MYELOPROLIFERATIVE NEOPLASM

EHA Library, Emmanuelle Verger, 100000

COMPARISON OF THREE DIAGNOSTIC METHODS TO DETECT CALRETICULIN MUTATIONS IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Francois Girodon, 100001

ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML

EHA Library, Cristina panuzzo, 100002

MUTATION ANALYSIS OF JAK2, MPL, CALR, ASXL1, TET2, IDH1, IDH2, DNMT3A, AND SF3B1 IN MYELOPROLIFERATIVE NEOPLASM

EHA Library, Jee Hyun Kong, 100003

MARKERS OF CLONAL HEMATOPOIESIS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Liubov Poluskina, 100004

HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY IMMUNE DEFICIENY DISEASES: A SINGLE CENTER EXPERIENCE

EHA Library, Turkan Patıroglu, 100005

GATA-1, BUT NOT FOG-1, FLI-1 OR CALR, IS UP-REGULATED IN ESSENTIAL THROMBOCYTHEMIA INDEPENDENTLY FROM JAK2 AND CALR MUTATIONS.

EHA Library, Ciro Rinaldi, 100006

PEGYLATED INTERFERON TREATMENT IMPROVES SURVIVAL IN POLYCYTHEMIA VERA PATIENTS: A SINGLE CENTER EXPERIENCE

EHA Library, Elena Crisà, 100007

TERT RS2736100_C POLYMORPHISM AS PREDISPOSITION FACTOR FOR MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Katalin Piroska Kiss, 100008

PATIENT SELF-CARE INTERVENTIONS: DO THEY IMPACT MPN-RELATED FATIGUE?

EHA Library, Robyn Scheber, 100009

CD4+ CELL COUNT ON DAY + 30 PREDICT OVERALL SURVIVAL AND TRANSPLANT RELATED MORTALITY IN ACUTE LEUKAEMIA PATIENTS AFTER ALLOPBSCT

EHA Library, Domenico Pastore, 100010

ULTRA-DEEP SEQUENCING (UDS) ALLOWS MORE SENSITIVE DETECTION OF THE D816V AND OTHER KIT GENE MUTATIONS IN SYSTEMIC MASTOCYTOSIS

EHA Library, Caterina De Benedittis, 100011

RUXOLITINIB VS BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA TREATED IN THE RESPONSE STUDY: A SUBGROUP ANALYSIS OF HYDROXYUREA- AND NON-HYDROXYUREA–TREATED PATIENTS

EHA Library, Francesco Passamonti, 100012